Cholesterol
- Generic Name
- Cholesterol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H46O
- CAS Number
- 57-88-5
- Unique Ingredient Identifier
- 97C5T2UQ7J
- Background
The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.
- Associated Conditions
- -
- Associated Therapies
- -
Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)
Phase 2
Recruiting
- Conditions
- Smith-Lemli-Opitz SyndromeHearing LossCone-Rod Dystrophy
- Interventions
- Drug: AntioxidantsDrug: Cholesterol
- First Posted Date
- 2013-01-23
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 100
- Registration Number
- NCT01773278
- Locations
- 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
Study of Smith-Lemli-Opitz Syndrome
Completed
- Conditions
- Smith-Lemli-Opitz Syndrome
- Interventions
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Target Recruit Count
- 130
- Registration Number
- NCT00001721
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath